AI Clinical Analysis
Advanced trial analysis powered by artificial intelligence
Total Analyses
247
Avg Confidence
94%
Insights Found
1,842
Active Now
3
Clinical AI Analysis StationUnknown
Unknown
Coordinator
Protocol
Compliance
Loading...
Recent Analyses
COVID-19 Vaccine Trial Phase III
Trial ID: NCT12345678
completed
Confidence:98%
Insights:12
High efficacy rate of 95.2% observed
Minimal adverse events reported
8/10/2026, 7:39:27 AM
Diabetes Management Study
Trial ID: NCT23456789
in progress
Confidence:85%
Insights:8
Promising early results
Patient compliance above expectations
8/10/2026, 6:09:27 AM
Hypertension Treatment Trial
Trial ID: NCT34567890
pending
8/10/2026, 3:09:27 AM
AI Insights
Enrollment Trend
15% increase in enrollment rate detected across Phase III trials
Safety Profile
No significant adverse events in last 30 days
Predictive Analysis
Trial NCT12345678 likely to meet primary endpoints